Weronika Magdalena Jabłońska

Ms. Weronika Magdalena Jabłońska

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2025 in Molecules
Verified
Journal Article
Open access
PDF file
MKMagdalena Kot
Magdalena Kot
ALAgata Lange
Agata Lange
WJWeronika Magdalena Jabłońska
Weronika Magdalena Jabłońska
AKAleksandra Kalińska
Aleksandra Kalińska
BNBarbara Nasiłowska
Barbara Nasiłowska
MGMarcin Gołębiewski
Marcin Gołębiewski
Bacterial infections are the primary cause of mastitis in dairy cattle. Fungal mastitis occurs in 1–12% of cases. Antibiotic therapy, the standard treatment for mastitis, has led to antibiotic-resistant bacteria, reducing treatment efficacy and increasing fungal mastitis occurrence. Antibiotics lack biocidal effects on fungi, which often exhibit resistance to antifungal agents. This study evaluated the antifungal properties of nanoparticles (NPs) against Candida albicans, Candida glabrata, Candida parapsilosis, Diutina rugosa var. rugosa, Diutina catenulata, and Diutina rugosa. Tested NPs included gold (AuNPs), silver (AgNPs), copper (CuNPs), iron with hydrophilic carbon coating (FeCNPs) (1.56–25 mg/L), and platinum (PtNPs) (0.625–10 mg/L), along with their complexes. Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) at 0.75–25 mg/L for AuNPs, AgNPs, CuNPs, and FeCNPs and 0.313–10 mg/L for PtNPs, as well as fungal sensitivity to standard antifungals, were determined. Each strain showed different sensitivities depending on the NPs used and their concentrations. C. glabrata was the most resistant to nanoparticles, while D. catenulata was the most susceptible. PtNPs and FeCNPs showed no or weak biocidal properties. Some mycotic-resistant strains were sensitive to nanoparticles. This study indicates a high in vitro antifungal potential for the application of nanoparticles, especially AgCuNPs, as a new effective non-antibiotic agent for the prevention and control of mycotic mastitis in dairy cattle.

Verified
Journal Article
Open access
PDF file
WJWeronika Magdalena Jabłońska
Weronika Magdalena Jabłońska
MGMarcin Gołębiewski
Marcin Gołębiewski
MKMagdalena Kot
Magdalena Kot
HMHenadzi Mardan
Henadzi Mardan
BPBartosz Pawliński
Bartosz Pawliński
AKAleksandra Kalińska
Aleksandra Kalińska
Innovative approaches in nanotechnology provide a potentially promising alternative to untreatable cases of mastitis caused by genus Prototheca spp. algae infections. Drying of the teats of the affected animals or culling are typically the outcomes of mastitis in dairy cattle caused by these pathogens. A major issue in both veterinary medicine and animal breeding is the Prototheca species’ widespread resistance to the current methods of managing infections and the available drugs, including antibiotics. Commercial antifungal preparations are also ineffective. Nanotechnology, an emerging discipline, has the potential to create an effective alternative treatment for protothecal mastitis. The aim of the paper is to combine the literature data on the use of nanotechnology in the control of mastitis, taking into account data on combating mastitis caused by Prototheca spp. infections. The databases employed were PubMed, Google Scholar, and Scopus, focusing on literature from the last 20 years to ensure relevance and currency. Studies conducted in vitro have demonstrated that nanomaterials have significant biocidal activity against mastitis infections of different etiologies. Analyzed research papers show that (NPs), such as AgNPs, CuNPs, AuNPs, etc., may not negatively impact various cell lines and may be effective agents in reducing the pathogens’ viability. However, it is also critical to assess the risks involved in using nanomaterials.

3 March 2026 in Biology
Verified
Journal Article
Open access
PDF file
MKMagdalena Kot
Magdalena Kot
WJWeronika Magdalena Jabłońska
Weronika Magdalena Jabłońska
ALAgata Lange
Agata Lange
AKAleksandra Kalińska
Aleksandra Kalińska
MGMarcin Gołębiewski
Marcin Gołębiewski
Fungal mastitis is rare but poses a significant problem for dairy farmers. It is often underestimated and under-researched, with most studies and treatments focusing on bacterial infections. Antibiotics are ineffective against fungi, and they exacerbate fungal mastitis. This study aimed to determine the antifungal properties of silver (Ag), gold (Au), copper (Cu), iron with a hydrophilic carbon coating (FeC), and platinum (Pt) nanoparticles (NPs) at five different concentrations, as well as their complexes, on the survival of fungal strains such as Pichia kudriavzevii, Wickerhamiella pararugosa, Saccharomyces cerevisiae, Cutaneotrichosporon mucoides, Wickerhamomyces anomalus, Coniochaeta hoffmannii, and Kluyveromyces marxianus. The strains’ susceptibility to 8 standard antifungals, along with MIC (minimal inhibitory concentration) and MFC (minimal fungicidal concentration) after NP treatment, was assessed. Clotrimazole and ketoconazole (10 µg) were most effective, while fluconazole (10 µg) and flucytosine (1 µg) showed the weakest activity. The AgCuNP complex demonstrated the strongest biocidal activity against all isolated strains, while FeCNPs and PtNPs showed very weak or no biocidal properties. The study’s results provide a basis for further in vivo research, indicating the great potential of nanoparticles in combating fungal mastitis, providing an innovative solution against infections caused by drug-resistant pathogens.

26 May 2026 in Molecules
Verified
Journal Article
Open access
PDF file
WJWeronika Magdalena Jabłońska
Weronika Magdalena Jabłońska
Urszula GuzikUrszula Guzik
Urszula Guzik
Danuta WojcieszyńskaDanuta Wojcieszyńska
Danuta Wojcieszyńska
The increasing presence of pharmaceutical compounds in aquatic environments poses a significant challenge for wastewater treatment systems worldwide. Among these emerging contaminants, bicyclic non-steroidal anti-inflammatory drugs (NSAIDs) are particularly concerning due to their high consumption, partial metabolism, and long-lasting persistence in wastewater. This review was prepared critically based on popular databases such as PubMed and the Google Scholar website, and using the modern Nested Knowledge platform. The bibliometric analysis was performed using the VosViewer program with the keywords co-occurrence method. The review aims to systematically compile and synthesize current knowledge on the impact of bicyclic non-steroidal anti-inflammatory drugs (NSAIDs) on biological wastewater treatment systems, with particular emphasis on activated sludge. It discusses how these compounds influence microbial community composition, metabolic activity, sludge structure, and overall treatment performance. Furthermore, the distribution of these contaminants in the environment and their degradation efficiency were analyzed. By integrating evidence from both laboratory and industrial studies, this article provides a comprehensive perspective on the environmental risks posed by bicyclic NSAIDs. Our findings also underscore the urgent need for systematic monitoring and adaptive management to mitigate the ecological impact of these widely used pharmaceuticals in the future.

4 September 2024 in Folia Pomeranae Universitatis Technologiae Stetinensis Agricultura, Alimentaria, Piscaria et Zootechnica
Verified
Journal Article
Closed access
JGJoanna Gruszczyńska
Joanna Gruszczyńska
KKKinga Konieckiewicz
Kinga Konieckiewicz
GŁGabriela Łyszkowska
Gabriela Łyszkowska
PJPaulina Jundziłł-Bogusiewicz
Paulina Jundziłł-Bogusiewicz
MBMilena Sylwia Bors
Milena Sylwia Bors
BGBeata Grzegrzółka
Beata Grzegrzółka
Mucopolysaccharidosis (MPS) are a group of metabolic diseases (7 types in human and 5 types in domestic dog), which result from the accumulation of glycosaminoglycans in cells, tissue, organs, causing their abnormal functioning. They are the result of a deficiency or total inactivity of catabolic enzymes responsible for the break down of glycosaminoglycans. MPSs are characterized by a wide spectrum of clinical symptoms. Skeletal deformation, organomegaly, delayed growth and corneal opacities are typical symptoms of the disease. This is a group of rare, inherited metabolic diseases that affect the body’s ability to break down mucopolysaccharides. The aim of the literature research was to present information on the mode of inheritance of mucopolysaccharidosis and the genetic basis of individual types, including the breeds of dogs in which a given type of disease was identified. Due to the complexity of symptoms, mucopolysaccharidoses are difficult to treat. The diagnosis of mucopolysaccharidoses uses clinical diagnostic methods based on screening methods and molecular diagnostics, which are characterized by accuracy and sensitivity similar to methods used in humans.